ARHGAP24 and neoplasm: Conversely, the volumes of tumor xenografts derived from HCCLM3 vector control and HCCLM3 ARHGAP24 overexpressing cells were 1845.22 ± 152.17 and 398.25 ± 73.89 mm3, respectively (P < 0.01; Figure 2G), suggesting that ARHGAP24 overexpression markedly inhibited tumor growth.